471 related articles for article (PubMed ID: 26531137)
61. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.
Macher BA; Galili U
Biochim Biophys Acta; 2008 Feb; 1780(2):75-88. PubMed ID: 18047841
[TBL] [Abstract][Full Text] [Related]
62. Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Taniyama K; Kamiike W; Mori M; Doki Y
Cancer Sci; 2013 Mar; 104(3):282-90. PubMed ID: 23240661
[TBL] [Abstract][Full Text] [Related]
63. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
64. Silencing the porcine iGb3s gene does not affect Galα3Gal levels or measures of anticipated pig-to-human and pig-to-primate acute rejection.
Butler JR; Skill NJ; Priestman DL; Platt FM; Li P; Estrada JL; Martens GR; Ladowski JM; Tector M; Tector AJ
Xenotransplantation; 2016 Mar; 23(2):106-16. PubMed ID: 27106872
[TBL] [Abstract][Full Text] [Related]
65. Role of anti-Gal alpha13Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood.
Pfeiffer S; Zorn GL; Kelishadi S; Oriol R; Wolf P; Pierson RN; Azimzadeh AM
Ann Thorac Surg; 2001 Nov; 72(5):1681-9; discussion 1690. PubMed ID: 11722065
[TBL] [Abstract][Full Text] [Related]
66. Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies.
Milland J; Yuriev E; Xing PX; McKenzie IF; Ramsland PA; Sandrin MS
Immunol Cell Biol; 2007; 85(8):623-32. PubMed ID: 17724458
[TBL] [Abstract][Full Text] [Related]
67. Intracellular expression in pig cells of anti-alpha1,3galactosyltransferase single-chain FV antibodies reduces Gal alpha1,3Gal expression and inhibits cytotoxicity mediated by anti-Gal xenoantibodies.
Vanhove B; Charreau B; Cassard A; Pourcel C; Soulillou JP
Transplantation; 1998 Dec; 66(11):1477-85. PubMed ID: 9869089
[TBL] [Abstract][Full Text] [Related]
68. Pig alpha1, 3galactosyltransferase: a major target for genetic manipulation in xenotransplantation.
Strahan K; Preece A; Gustafsson K
Front Biosci; 1996 Jul; 1():e34-41. PubMed ID: 9159243
[TBL] [Abstract][Full Text] [Related]
69. Identification of human preformed antibody targets in GTKO pigs.
Burlak C; Wang ZY; Chihara RK; Lutz AJ; Wang Y; Estrada JL; Tector AJ
Xenotransplantation; 2012; 19(2):92-101. PubMed ID: 22497511
[TBL] [Abstract][Full Text] [Related]
70. Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.
Unfer RC; Hellrung D; Link CJ
Cancer Res; 2003 Mar; 63(5):987-93. PubMed ID: 12615713
[TBL] [Abstract][Full Text] [Related]
71. Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse.
Thall AD; Malý P; Lowe JB
J Biol Chem; 1995 Sep; 270(37):21437-40. PubMed ID: 7545161
[TBL] [Abstract][Full Text] [Related]
72. The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene.
Milland J; Christiansen D; Lazarus BD; Taylor SG; Xing PX; Sandrin MS
J Immunol; 2006 Feb; 176(4):2448-54. PubMed ID: 16456004
[TBL] [Abstract][Full Text] [Related]
73. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
LaTemple DC; Henion TR; Anaraki F; Galili U
Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064
[TBL] [Abstract][Full Text] [Related]
74. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
75. Synthesis of alpha-gal epitopes on influenza virus vaccines, by recombinant alpha 1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody.
Henion TR; Gerhard W; Anaraki F; Galili U
Vaccine; 1997 Aug; 15(11):1174-82. PubMed ID: 9286041
[TBL] [Abstract][Full Text] [Related]
76. Gal alpha(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognized by naturally occurring cytotoxic human antibodies.
Vaughan HA; Loveland BE; Sandrin MS
Transplantation; 1994 Oct; 58(8):879-82. PubMed ID: 7524207
[TBL] [Abstract][Full Text] [Related]
77. Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model.
Repik PM; Strizki JM; Galili U
J Gen Virol; 1994 May; 75 ( Pt 5)():1177-81. PubMed ID: 7513744
[TBL] [Abstract][Full Text] [Related]
78. Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.
Osman N; McKenzie IF; Ostenried K; Ioannou YA; Desnick RJ; Sandrin MS
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14677-82. PubMed ID: 9405672
[TBL] [Abstract][Full Text] [Related]
79. A possible role for the alpha 1-->3 galactosyl epitope and the natural anti-gal antibody in oncogenesis.
Gollogly L; Castronovo V
Neoplasma; 1996; 43(5):285-9. PubMed ID: 8996545
[TBL] [Abstract][Full Text] [Related]
80. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.
Breimer ME
Xenotransplantation; 2011; 18(4):215-28. PubMed ID: 21848538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
